COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,544 Articles (22,881 medRxiv, 8,663 bioRxiv)

Most recent first Previous |  Page 284: Articles 2831-2840  | Next

Attenuated replication and damaging effects of SARS-CoV-2 Omicron in an intestinal epithelial barrier model
Volcic, M., Nchioua, R., Pastorio, C., Zech, F., Read, C., Walther, P., Kirchhoff, F.
10.1101/2024.02.28.582510 — Posted: 2024-02-28
Telemedicine's Impact on Diabetes Care during the COVID-19 Pandemic: A Cohort Study in a Large Integrated Healthcare System
Patel, R., Huang, J., Hsueh, L., Gopalan, A., Millman, A., Franklin, I., Reed, M.
10.1101/2024.02.25.24303335 — Posted: 2024-02-27
Risk of Adverse Events Following Monovalent Third or Booster Dose of COVID-19 mRNA Vaccination in U.S. Adults Ages 18 Years and Older
Shoaibi, A., Matuska, K., Lloyd, P. C., Wong, H. L., Gruber, J. F., Clarke, T. C., Cho, S., Lassman, E., Lyu, H., McEvoy, R., Wan, Z., Hu, M., Akhtar, S., Jiao, Y., Chillarige, Y., Beachler, D., Secora, A., Selvam, N., Djibo, D. A., McMahill Walraven, C. N., Seeger, J. D., Amend, K. L., Song, J. N., Clifford, R., Kelman, J. A., Forshee, R. A., Anderson, S. A.
10.1101/2024.02.20.24303089 — Posted: 2024-02-27
TISSUE-SPECIFIC METABOLOMIC REPROGRAMMING DETERMINES THE DISEASE PATHOPHYSIOLOGY OF SARS-COV-2 VARIANTS IN HAMSTER MODEL
Sardarni, U. K., Ambikan, A., Acharya, A., Johnson, S. D., Avedissian, S. N., Vegvari, A., Neogi, U., Byrareddy, S.
10.1101/2024.02.25.581989 — Posted: 2024-02-27
Deep plasma proteomics with data-independent acquisition: A fastlane towards biomarkers identification.
Ward, B., Pyr dit Ruys, S., Balligand, J.-L., Belkhir, L., Cani, P. D., Collet, J.-F., De Greef, J., Gatto, L., Haufroid, V., Jodogne, S., Kabamba, B., Lingurski, M., Yombi, J. C., Vertommen, D., Elens, L.
10.1101/2024.02.23.581160 — Posted: 2024-02-26
Heterologous Prime-Boost with Immunologically Orthogonal Protein Nanoparticles for Peptide Immunofocusing
Bhattacharya, S., Jenkins, M. C., Keshavarz-Joud, P., Bourque, A. R., White, K., Barkane, A. M. A., Bryksin, A. V., Hernandez, C., Kopylov, M., Finn, M. G.
10.1101/2024.02.24.581861 — Posted: 2024-02-26
Biochemical characterization of naturally occurring mutations in SARS-CoV-2 RNA-dependent RNA polymerase
Danda, M., Klimesova, A., Kuskova, K., Dostalkova, A., Pagacova, A., Prchal, J., Kapisheva, M., Ruml, T., Rumlova, M.
10.1101/2024.02.24.581855 — Posted: 2024-02-26
Prognostic factors for mortality, ICU, MIS-C and hospital admission due to SARS-CoV-2 in paediatric patients: A systematic review and meta-analysis
Vardavas, C. I., Nikitara, K., Mathioudakis, A., Delialis, D., Marou, V., Ramesh, N., Stamatelopoulos, K., Georgiopoulos, G., Phalkey, R., Leonardi-Bee, J., Deogan, C., Lamb, F., Mougkou, A., Pharris, A., Suk, J. E.
10.1101/2024.02.23.23298451 — Posted: 2024-02-24
Global patterns of rebound to normal RSV dynamics following COVID-19 suppression
Thindwa, D., Li, K., Cooper-Wootton, D., Zheng, Z., Pitzer, V. E., Weinberger, D. M.
10.1101/2024.02.23.24303265 — Posted: 2024-02-24
Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial
HITES, M., MASSONNAUD, C. R., JAMARD, S., Goehringer, F., DANION, F., REIGNIER, J., DE CASTRO, N., GAROT, D., LARRANAGA LAPIQUE, E., LACOMBE, K., TOLSMA, V., FAURE, E., MALVY, D., STAUB, T., COURJON, J., CAZENAVE-ROBLOT, F., DYRHOL RIISE, A. M., LE TURNIER, P., MARTIN BLONDEL, G., ROGER, C., AKINOSOGLOU, K., LE MOING, V., PIROTH, L., SELLIER, P., LESCURE, X., TROSEID, M., CLEVENBERGH, P., DALGARD, O., GALLIEN, S., GOUSSEFF, M., LOUBET, P., BOUNES - VARDON, F., VISEE, C., BELKHIR, L., BOTELHO-NEVERS, E., CABIE, A., KOTANIDOU, A., LANTERNIER, F., ROUVEIX-NORDON, E., SILVA, S., THIERY, G., POIGNA
10.1101/2024.02.23.24302586 — Posted: 2024-02-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).